Skip to main content
Article thumbnail
Location of Repository

Effect of high-dose milnacipran in patients with depression

By Masatoshi Hayashi, Masaru Mimura, Tempei Otsubo and Kunitoshi Kamijima


To investigate the antidepressant effect of high-dose milnacipran, we retrospectively compared three groups of inpatients with major depression; those who were given milnacipran >100–150 mg/day (high-dose milnacipran group), those treated with milnacipran at maximum doses of 50–100 mg/day (standard-dose milnacipran group), and those treated with paroxetine at maximum doses of 40 mg/day (paroxetine group). The Hamilton Depression Rating Scale (HAM-D) scores of the three groups showed significant decrease at discharge compared to the scores at admission, indicating improvement of depressive symptoms for each group. However, the mean HAM-D score on admission was significantly lower for the standard-dose milnacipran group than the high-dose milnacipran and paroxetine groups. Additional intermediate assessment of the high-dose milnacipran group showed that the effect of milnacipran was dose-dependent with an additional improvement when patients were increase from 100 to 150 mg/day. These results suggest that patients suffering from moderate to severe depression with relative high HAM-D scores may benefit from treatment with high-dose milnacipran

Topics: Letter
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2003). A clinical case of relapsed depression improved with high dose of milnacipran.
  2. (1998). A double-blind comparison of the effi cacy and safety of milnacipran and fl uoxetine in depressed inpatients. Int Clin Psychopharmacology,
  3. (1986). An early clinical trial of midalcipran, 1-phenyl-1-diethyl aminocarbonyl 2-aminomethyl cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant. Curr Ther Res Clin Exp,
  4. (2002). Clinical experience of milnacipran hydrochloraide in the stress hospital ward [Japanese].
  5. (2004). Controlled comparison of two different doses of milnacipran in major depressive outpatients. Int Clin Psychopharmacol,
  6. (1989). Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients.
  7. (1996). Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psychopharmacol,
  8. (1985). Plasma levels of F 2207, midalcipran, a novel antidepressant, after single oral administration in volunteers.
  9. (1990). Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients: A new approach in dose ranging studies. Int Clin Psychopharmacol,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.